Probe: CSP 3/CSP 7 (3p11.1-q11.1/7p11.1-q11.1)
GLP P16/CSP (9p21/17p11.1-q11.1)
1. Etiology of patients’ with hematuria in the whole urinary system, and the diagnosis of benign and malignant bladder, ureter and pelvis hematuria.
2. Early diagnosis of urinary system malignant tumor by morphological abnormalities detection, and the determination of a personalized treatment program.
3. For bladder tumor post-operation recurrence monitoring and based on the post-operation bladder cancer recurrence characteristics, provide non-invasive periodic monitoring methods.